What is NDC 66621-0150?

66621-0150 is the product NDC for Anascorp, Centruroides fab2 antivenin (Equine) 7 mg/mL injection, powder, lyophilized, for solution, listed with the FDA by Rare Disease Therapeutics, Inc. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Anascorp (Centruroides (scorpion) immune F(ab)2 (equine)).

What is the active ingredient?

Centruroides fab2 antivenin (Equine).

Rare Disease Therapeutics, Inc, NDC labeler code 66621. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Anascorp?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Anascorp NDC 66621-0150 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)66621-0150Labeler and product segments. Claims need a package NDC.

Product NDC at billing width66621-0150Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
66621-0150-2	66621015002	1 VIAL in 1 CARTON (66621-0150-2) / 10 mL in 1 VIAL (66621-0150-1)Marketed from Aug 3, 2011

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Anascorp
Generic name (nonproprietary): centruroides (scorpion) immune f(ab)2 (equine)
Active ingredients: Centruroides fab2 antivenin (Equine) — 7 mg/mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Rare Disease Therapeutics, IncNDC labeler code 66621
Product type: Plasma derivative
Marketing category: BLA — Biologics License ApplicationApplication BLA 125335
Marketing start: Aug 3, 2011
Listing expires: Dec 31, 2026
Other FDA classes: Antivenins (Chemical structure)Passively Acquired Immunity (Physiologic effect)Venom Neutralization (Mechanism)
Identifiers: Product ID 66621-0150_d0c33dec-842e-4cc0-9d8f-515d6efd8a0cSPL ID d0c33dec-842e-4cc0-9d8f-515d6efd8a0c
Pharmacologic class: Antivenin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N466621015002 followed by a unit qualifier and the quantity

Package 66621-0150-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 66621-0150

What is NDC 66621-0150?: 66621-0150 is the product NDC for Anascorp, Centruroides fab2 antivenin (Equine) 7 mg/mL injection, powder, lyophilized, for solution, listed with the FDA by Rare Disease Therapeutics, Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Anascorp (Centruroides (scorpion) immune F(ab)2 (equine)).
What is the active ingredient?: Centruroides fab2 antivenin (Equine).
Who is the labeler?: Rare Disease Therapeutics, Inc, NDC labeler code 66621. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Anascorp?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.